This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koibuchi, N. Articles by Chin, W. W. Search for Related Content PubMed PubMed Citation Articles by Koibuchi, N. Articles by Chin, W. W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LEVOTHYROXINE Medline Plus Health Information Seniors' Health

Promoter-Specific Regulation of the Brain-Derived Neurotropic Factor Gene by Thyroid Hormone in the Developing Rat Cerebellum¹

Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115

Address all correspondence and requests for reprints to: Dr. Noriyuki Koibuchi, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, 75 Francis Street, Thorn 1009, Boston, Massachusetts 02115. E-mail: koibuchi{at}rascal.med.harvard.edu

Thyroid hormone (TH) plays a critical role in normal cerebellar development. However, the molecular mechanisms of TH action in the developing cerebellum are not fully understood. This action could be exerted in part through brain-derived neurotropic factor (BDNF), as cerebellar BDNF messenger RNA (mRNA) expression is lower, and replacement of BDNF partially reverses the abnormal neurogenesis in the hypothyroid rat. The rat BDNF gene consists of four noncoding exons (exons I–IV), each of which is linked to a different promoter, and a protein-coding exon (exon V). To study promoter-specific regulation of the BDNF gene by TH, ribonuclease protection assay of each exon mRNA was performed using total developing rat cerebellar RNA. During cerebellar development, all exon mRNAs were detected, but with different expression patterns; among noncoding exon mRNAs, exon II mRNA was the most abundant. Daily TH replacement induced a 3-fold increase in exon II mRNA on postnatal day (P) 15. On P30, exon II mRNA was still much greater in the TH-replaced animal. Exon I mRNA was detected on P2 and P7. However, in contrast to exon II mRNA, TH treatment suppressed the expression of exon I mRNA on P2. Exon III and IV mRNAs were not detected on P2 and P7, but small amounts were observed starting on P15 in TH-replaced animals. They were not detected by P30 in hypothyroid animals. In contrast, in the cerebral cortex, although all exons are differentially regulated during development, the expression of each mRNA was not significantly altered by TH. These results indicate that TH regulates BDNF gene expression in a promoter-, developmental stage-, and brain region-specific manner, which may play an important role in region- and stage-specific regulation of brain development by TH.

This article has been cited by other articles:

				V. L. Adams, R. L. Goodman, A. K. Salm, L. M. Coolen, F. J. Karsch, and M. N. Lehman Morphological Plasticity in the Neural Circuitry Responsible for Seasonal Breeding in the Ewe Endocrinology, October 1, 2006; 147(10): 4843 - 4851. [Abstract] [Full Text] [PDF]

				H. Heuer and C. A. Mason Thyroid Hormone Induces Cerebellar Purkinje Cell Dendritic Development via the Thyroid Hormone Receptor {alpha}1 J. Neurosci., November 19, 2003; 23(33): 10604 - 10612. [Abstract] [Full Text] [PDF]

				R. Martinez and F. C. A. Gomes Neuritogenesis Induced by Thyroid Hormone-treated Astrocytes Is Mediated by Epidermal Growth Factor/Mitogen-activated Protein Kinase-Phosphatidylinositol 3-Kinase Pathways and Involves Modulation of Extracellular Matrix Proteins J. Biol. Chem., December 13, 2002; 277(51): 49311 - 49318. [Abstract] [Full Text] [PDF]

				W. M. Wood, V. D. Sarapura, J. M. Dowding, W. W. Woodmansee, D. J. Haakinson, D. F. Gordon, and E. C. Ridgway Early Gene Expression Changes Preceding Thyroid Hormone-Induced Involution of a Thyrotrope Tumor Endocrinology, February 1, 2002; 143(2): 347 - 359. [Abstract] [Full Text] [PDF]

				L. D. Miller, K. S. Park, Q. M. Guo, N. W. Alkharouf, R. L. Malek, N. H. Lee, E. T. Liu, and S.-y. Cheng Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell Proliferation Mol. Cell. Biol., October 1, 2001; 21(19): 6626 - 6639. [Abstract] [Full Text] [PDF]

				P. M. Yen Physiological and Molecular Basis of Thyroid Hormone Action Physiol Rev, July 1, 2001; 81(3): 1097 - 1142. [Abstract] [Full Text] [PDF]

				K. Hashimoto, F. H. Curty, P. P. Borges, C. E. Lee, E. D. Abel, J. K. Elmquist, R. N. Cohen, and F. E. Wondisford An unliganded thyroid hormone receptor causes severe neurological dysfunction PNAS, March 1, 2001; (2001) 51454698. [Abstract] [Full Text]

				K. Hashimoto, F. H. Curty, P. P. Borges, C. E. Lee, E. D. Abel, J. K. Elmquist, R. N. Cohen, and F. E. Wondisford An unliganded thyroid hormone receptor causes severe neurological dysfunction PNAS, March 27, 2001; 98(7): 3998 - 4003. [Abstract] [Full Text] [PDF]